उत्पाद वर्णन
Empagliflozin 12.5 mg + Metformin 500 mg IRIndication: Used in adults with type 2 diabetes mellitus (T2DM) to improve blood sugar control as an adjunct to diet and exercise. CombinesSGLT2 inhibitor(Empagliflozin) and biguanide (Metformin) for dual action on glucose regulation. Not for type 1 diabetes or diabetic ketoacidosis.
FAQs of EMPASUG-M 500/12.5:
Q: What are the active ingredients in EMPASUG-M 500/12.5?
A: EMPASUG-M 500/12.5 contains Empagliflozin 12.5 mg and Metformin 500 mg IR as its active ingredients.
Q: What type of drug is EMPASUG-M 500/12.5 classified as?
A: EMPASUG-M 500/12.5 is classified as a General Medicine.
Q: In what physical form is EMPASUG-M 500/12.5 available?
A: EMPASUG-M 500/12.5 is available in tablet form.
Q: How is EMPASUG-M 500/12.5 packaged?
A: EMPASUG-M 500/12.5 is packaged with a quantity of 100 tablets per box.
Q: What is the salt composition of EMPASUG-M 500/12.5?
A: The salt composition of EMPASUG-M 500/12.5 is Empagliflozin 12.5 mg combined with Metformin 500 mg IR.